Skip to content

First immunization of premature infants born before 33 weeks of gestation; safe at home or is cardiorespiratory monitoring in the hospital necessary?

First immunization of premature infants born before 33 weeks of gestation; safe at home or is cardiorespiratory monitoring in the hospital necessary? - Cardiorespiratory disturbances after 1st vaccination in premature infants

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41573
Enrollment
50
Registered
2013-03-05
Start date
2015-01-03
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

verstoringen van vitale functies na reguliere vaccinatie cardiorespiratory incidents post-immunization safety of immunization

Interventions

None listed

Sponsors

Medisch Centrum Alkmaar
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: children born prematurely (gestational age

Exclusion criteria

Exclusion criteria: No approval of parent. Need for respiratory support or tubefeeding at home. Any known congenital or acquired medical condition potentially affecting cardiorespiratory stability.

Design outcomes

Primary

MeasureTime frame
Number and characteristics of the following cardiorespiratory events: - apnea - bradycardia - cyanosis definitions - apnea = isolated respiratory pause >= 20 seconds or respiratory pause > 15 seconds combined with a heart rate = 20 seconds. - cyanosis = transcutaneous oxygensaturation 15 seconds.

Secondary

MeasureTime frame
- bodytemperature - local skin reaction - changed nutritional pattern - changed sleep pattern - need for analgesia

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)